Author Question: The nurse is caring for a client with pre-eclampsia, and is performing an assessment of deep tendon ... (Read 31 times)

bobbysung

  • Hero Member
  • *****
  • Posts: 519
The nurse is caring for a client with pre-eclampsia, and is performing an assessment of deep tendon reflexes and clonus. The client's results demonstrate normal reflexes. The nurse would document these findings as:
 
  A) 1+. B) 2+. C) 4+. D) 3+.

Question 2

The nurse would consider which of the following clients at greatest risk for hemolytic disease?
 
  A) The mother has Rh-negative blood and the baby has Rh-positive blood. B) The mother and baby both have Rh-positive blood. C) The mother and baby have Rh-negative blood. D) The mother has Rh-positive blood and the baby has Rh-negative blood.



kusterl

  • Sr. Member
  • ****
  • Posts: 315
Answer to Question 1

B

Answer to Question 2

A



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The use of salicylates dates back 2,500 years to Hippocrates's recommendation of willow bark (from which a salicylate is derived) as an aid to the pains of childbirth. However, overdosage of salicylates can harm body fluids, electrolytes, the CNS, the GI tract, the ears, the lungs, the blood, the liver, and the kidneys and cause coma or death.

Did you know?

According to the FDA, adverse drug events harmed or killed approximately 1,200,000 people in the United States in the year 2015.

Did you know?

According to the National Institute of Environmental Health Sciences, lung disease is the third leading killer in the United States, responsible for one in seven deaths. It is the leading cause of death among infants under the age of one year.

Did you know?

Though newer “smart” infusion pumps are increasingly becoming more sophisticated, they cannot prevent all programming and administration errors. Health care professionals that use smart infusion pumps must still practice the rights of medication administration and have other professionals double-check all high-risk infusions.

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

For a complete list of videos, visit our video library